A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors

Clinical Trial ID NCT02261220

Rank	Title	Journal	Year	PubWeight™‹?›
1	Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.	Oncoimmunology	2015	1.06
2	Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade.	J Clin Invest	2015	0.98
3	Immune checkpoint inhibitors: therapeutic advances in melanoma.	Ann Transl Med	2015	0.87
4	Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.	Hum Vaccin Immunother	2016	0.82
5	Cancer stem cells in small cell lung cancer.	Transl Lung Cancer Res	2016	0.80
6	Cellular and molecular biology of small cell lung cancer: an overview.	Transl Lung Cancer Res	2016	0.79
7	Emerging therapeutic targets in metastatic progression: A focus on breast cancer.	Pharmacol Ther	2016	0.79
8	Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect.	J Immunol Res	2015	0.78
9	Therapeutic targets and new directions for antibodies developed for ovarian cancer.	MAbs	2016	0.75
10	Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma.	World J Gastroenterol	2016	0.75